SYNCOM FORMU (I) LTD
SYNCOMF · General/Diversified · NSE
₹14
Current Market Price
Fair Value (DCF)
₹14
Discount to FV
+3.2%
Updated just now
YieldIQ Score
68/100
Piotroski F-Score
6/9
Economic Moat
Wide
Confidence
48%
ROE
14.4%
Debt/Equity
0.01
WACC
11.1%
Market Cap
₹1,308 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
20.6%
Return on capital employed
EV / EBITDA
11.5×
Enterprise multiple
Debt / EBITDA
0.0×
Leverage vs earnings
Interest Coverage
93.3×
EBIT covers interest
Current Ratio
4.55×
Short-term liquidity
Asset Turnover
1.18×
Revenue per ₹ of assets
Revenue CAGR (3Y)
30.0%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹13.91
Bear case
Discount -78.3%
Base case
Discount +3.1%
Bull case
Discount +19.2%
Ratio Trends
SYNCOMF · last 4 annual periods
ROE
14.4%
ROCE
20.6%
Operating Margin
—
Debt / Equity
0.01×
PE
65.5×
EV / EBITDA
18.6×
Historical Financials
SYNCOMF · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 yfinance | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹218 Cr | ₹222 Cr | ₹259 Cr | ₹457 Cr | +28.1% |
| EBITDA | ₹32.0 Cr | ₹34.3 Cr | ₹43.0 Cr | ₹71.4 Cr | +30.7% |
| EBIT | — | ₹29.7 Cr | ₹38.4 Cr | — | +9.0% |
| PAT | ₹19.8 Cr | ₹20.1 Cr | ₹25.3 Cr | ₹49.4 Cr | +35.7% |
| EPS (diluted) | — | ₹0.24 | ₹0.34 | — | +12.3% |
| CFO | ₹16.3 Cr | ₹10.5 Cr | ₹-6.0 Cr | ₹23.4 Cr | +12.8% |
| CapEx | ₹-11.3 Cr | ₹-20.6 Cr | ₹-8.1 Cr | ₹-10.0 Cr | — |
| FCF | ₹5.0 Cr | ₹-10.1 Cr | ₹-14.1 Cr | ₹13.5 Cr | +39.0% |
| Total Assets | ₹308 Cr | ₹378 Cr | ₹405 Cr | ₹413 Cr | +10.3% |
| Total Debt | ₹57.8 Cr | ₹83.2 Cr | ₹72.5 Cr | ₹4.6 Cr | -57.0% |
| Shareholders' Equity | ₹222 Cr | ₹256 Cr | ₹288 Cr | ₹342 Cr | +15.5% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
SYNCOMF vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
 SAKAR SAKAR | — | — | Pending | 6.1% | — |
BETA BETA | — | — | Pending | 16.9% | — |
 VENUSREM VENUSREM | — | — | Pending | 8.1% | — |
JAGSNPHARM JAGSONPAL PHARMACEUTICALS | -48.1% | 50 | Above Fair Value | 16.7% | 28.7× |
 BAJAJHCARE BAJAJHCARE | — | — | Pending | 3.0% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for SYNCOMF in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. SYNCOM FORMU (I) LTD (SYNCOMF.NS) trades at 13.91 vs a model fair value of 14.35, a gap of 3.2%. Piotroski F-score: 6/9. Moat label: Wide...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of SYNCOMF →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for SYNCOMF →
Compare
Head-to-head with peers
Compare SYNCOMF side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse SYNCOMFNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.